Abstract
Background
Non-ionic low osmolar contrast agents are widely used during coronary angiography. As these agents cause activation of thrombotic pathways in vitro, this may have potentially significant clinical impact. However, limited evidence exists as to their in vivo effects from selective coronary cannulation.
Methods
We initially performed an in vitro experiment to assess the effect of serial contrast (Iomeprol 300, Bracco) dilution on platelet indices [mean platelet count (MPC), platelet volume (MPV), platelet granularity (MPG)]. The in vivo effect of contrast injection on platelet activation markers [soluble P-selectin (sPsel), soluble CD40 ligand (sCD40L)], MPC, MPV, MPG, haemoglobin and haematocrit was subsequently determined in 35 patients (mean age 58 ± 11; 22 males) undergoing cardiac catheterisaton.
Results
No significant in vitro effect of contrast on MPC or MPV was seen but there was a significant increase in MPG (p = 0.40, 0.10 and 0.01, respectively). In the in vivo study, there was a reduction in mean haemoglobin and haematocrit levels, suggesting an average increase in plasma volume of 6.5 ± 5.8%. The in vivo effect of Iomeprol was associated with an unadjusted reduction in sPsel concentrations (p = 0.04) and MPV (p < 0.05), with denser platelets (p < 0.05). There was no difference in MPC or sCD40L concentration (both p = NS). After adjustment for the haemodilution effect, no significant reduction in P-sel levels was seen with contrast (p = 0.27), although the adjusted post-contrast change in MPG (p = 0.01), MPC (p = 0.01) and sCD40L (p < 0.05) levels were significant.
Conclusion
Low osmolar contrast led to a minimal effect on soluble and physical indices of platelets within the coronary artery,
primarily due to plasma volume expansion.
Similar content being viewed by others
References
Grainger R, Dawson P (1991) Guidelines for the use of low osmolar intravascular contrast agents. Royal College of Radiologists, London
American College of Radiology Committee on Drugs and Contrast Media (1991) Manual on Iodinated Contrast Media, 4.1 edn. American College of Radiology, Reston, VA
Scheller B, Hennen B, Pohl A, Schieffer H, Markwirth T (2001) Acute and subacute stent occlusion; risk-reduction by ionic contrast media. Eur Heart J 22:385–391
Davidson CJ, Laskey WK, Hermiller JB, Harrison JK, Matthai W Jr, Vlietstra RE, Brinker JA, Kereiakes DJ, Muhlestein JB, Lansky A, Popma JJ, Buchbinder M, Hirshfeld JW Jr (2000) Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial. Circulation 101:2172–2177
Malekianpour M, Bonan R, Lesperance J, Gosselin G, Hudon G, Doucet S, Laurier J, Duval D (1998) Comparison of ionic and nonionic low osmolar contrast media in relation to thrombotic complications of angioplasty in patients with unstable angina. Am Heart J 135:1067–1075
Chronos NA, Goodall AH, Wilson DJ, Sigwart U, Buller NP (1993) Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology. Circulation 88:2035–2044
Gabelmann A, Haberstroh J, Weyrich G (2001) Ionic and non-ionic contrast agent-mediated endothelial injury. Quantitative analysis of cell proliferation during endothelial repair. Acta Radiol 42:422–425
Albanese JR, Venditto JA, Patel GC, Ambrose JA (1995) Effects of ionic and nonionic contrast media on in vitro and in vivo platelet activation. Am J Cardiol 76:1059–1063
Blann AD, Nadar SK, Lip GY (2003) The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 24:2166–2179
Henn V, Steinbach S, Buchner K, Presek P, Kroczek RA (2001) The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporarily limited by coexpressed CD40. Blood 98:1047–1054
Van Beaumont W, Underkofler S, Van Beaumont S (1981) Erythrocyte volume, plasma volume, and acid-base change in exercise and heart dehydration. J Appl Physiol Respir Environ Exerc Physiol 50:1255–1262
Galloti A, Uggeri F, Favilla A, Cabrini M, Hae¨n C (1994) The chemistry of iomeprol and physico-chemical properties of its aqueous solutions and pharmaceutical formulations. Eur J Radiol 18:S1–12
Scheller B, Hennen B, Thunenkotter T, Mrowietz C, Markwirth T, Schieffer H, Jung F (1999) Effect of X-ray contrast media on blood flow properties after coronary angiography. Thromb Res 96:253–260
Murakami R, Tajima H, Kumazaki T, Yamamoto K (1998) Effect of iodixanol on renal function immediately after abdominal angiography. Clinical comparison with iomeprol and ioxaglate. Acta Radiol 39:368–371
Davidson CJ, Mark DB, Pieper KS, Kisslo KB, Hlatky MA, Gabriel DA, Bashore TM (1990) Thrombotic and cardiovascular complications related to non-ionic contrast media during cardiac catheterization; analysis of 8,517 patients. Am J Cardiol 65:1481–1484
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jaumdally, R.J., Varma, C., MacFadyen, R.J. et al. Effects of low osmolar contrast (iomeprol) on haemorheology and platelet activation in patients with coronary artery disease. J Thromb Thrombolysis 23, 189–194 (2007). https://doi.org/10.1007/s11239-006-9048-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-006-9048-x